News and Announcements
YPB bolsters team with Global COO appointment
- Published August 03, 2015 3:37PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
3rd August 2015, ASX Announcement
Anti-counterfeiting technology company YPB Group Ltd (ASX:YPB) has appointed Mr Jens Michael as Global Chief Operating Officer (COO), to be based in the recently announced YPB regional hub in Bangkok, Thailand.
With extensive experience across Southeast Asia, Australia, NZ and Europe, Mr Michael has been involved in a broad range of senior management roles including sales, marketing and general management with experience spanning the healthcare and consumer industry, market expansion and distribution.
Most recently Mr Michael served as Pan-ASEAN Regional Vice President for a US$1.7 billion revenue multinational medical technology company. Prior to that he was Contry HEad for CHF5 billion revenue market expansion services businesses.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
